Sunscreen Ingredient Legislation Could Ride Wave Of Momentum
This article was originally published in The Rose Sheet
Executive Summary
Legislators and stakeholders are optimistic that the Sunscreen Innovation Act, which calls for an acceleration of FDA’s review of sunscreen active-ingredient time-and-extent applications, will pass this year. The House version of the bill is expected to advance first.
You may also be interested in...
Sunscreen Bill Would Expedite TEA Decisions, Set Deadlines
The Sunscreen Innovation Act, introduced in both the House and the Senate, would streamline the process for FDA review of sunscreen TEAs and impose deadlines for agency action.
Reps Prep Sunscreen Filter Legislation; FDA Frustrated By Backlog
Without swift FDA action on eight sunscreen filters pending review, legislators intend to introduce a bill to alter the agency’s sunscreen approval process. House members questioned FDA Center for Drug Evaluation and Research Director Janet Woodcock on the status of the applications, some of which have been under agency review for more than 10 years.
ICCS President Hill On Growing Regulatory Confidence In Alternative Testing Methodologies
In the year since its establishment, the International Collaboration on Cosmetics Safety has worked to engage with regulators as they build frameworks for assessing cosmetic safety without animal tests. ICCS president and CEO Erin Hill discusses current challenges and what lies ahead.